Brief: Pasithea Therapeutics Receives Letter From Nasdaq Advising Co Granted Extension To Regain Compliance With Listing Requirement
20/07/2023 13:51
July 20 (Reuters) - Pasithea Therapeutics Corp KTTA.O :
* PASITHEA THERAPEUTICS- ON JULY 19, GOT LETTER FROM NASDAQ
ADVISING CO GRANTED EXTENSION TO JAN 15, 2024, TO REGAIN
COMPLIANCE WITH LISTING REQUIREMENT
Further company coverage: KTTA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pasithea Therapeutics
See all newsPasithea Therapeutics Corp reports results for the quarter ended June 30 - Earnings Summary
Pasithea Therapeutics Corp expected to post a loss of 16 cents a share - Earnings Preview
Brief: Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data
Brief: Pasithea Therapeutics Announces Closing Of $60 Million Public Offering Of Common Stock
Pasithea Therapeutics jumps after $60 million public offering announcement